Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer

Journal of Surgical Oncology

Volumn 106, Issue 4, 2012, Pages 462-468

  Wu, Hui ^a   Xu, Jian Bo ^a   He, Yu Long ^a   Peng, Jian Jun ^a   Zhang, Xin Hua ^a   Chen, Chuang Qi ^a   Li, Wen ^a   Cai, Shi Rong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

angiogenesis; gastric cancer; lymphangiogenesis; tumor associated macrophages

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY D2-40; VASCULOTROPIN; VASCULOTROPIN C;

ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CANCER CELL; CANCER INVASION; CELL CULTURE; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROSA; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; CELL LINE, TUMOR; COCULTURE TECHNIQUES; FEMALE; HUMANS; LYMPHANGIOGENESIS; MACROPHAGES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84865152899     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23110     Document Type: Article

References (36)

1. Biswas SK, Sica A, Lewis CE,: Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms. J Immunol 2008; 180: 2011-2017.
2. Gordon S,: Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35. (Pubitemid 37328697)
3. Kurahara H, Shinchi H, Mataki Y, et al.: Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 2011; 167: e211-e219.
4. Puig-Kroger A, Sierra-Filardi E, Dominguez-Soto A, et al.: Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res 2009; 69: 9395-9403.
5. Luo Y, Zhou H, Krueger J, et al.: Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 2006; 116: 2132-2141. (Pubitemid 44162322)
6. Chen JJ, Lin YC, Yao PL, et al.: Tumor-associated macrophages: The double-edged sword in cancer progression. J Clin Oncol 2005; 23: 953-964. (Pubitemid 46202315)
7. Ishigami S, Natsugoe S, Tokuda K, et al.: Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res 2003; 23: 4079-4083. (Pubitemid 37474368)
8. Coffelt SB, Hughes R, Lewis CE,: Tumor-associated macrophages: Effectors of angiogenesis and tumor progression. Biochim Biophys Acta 2009; 1796: 11-18.
9. Craig M, Ying C, Loberg RD,: Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo. J Cell Biochem 2008; 103: 1-8.
10. Lamagna C, Aurrand-Lions M, Imhof BA,: Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 2006; 80: 705-713. (Pubitemid 44835885)
11. Zhang B, Wang J, Gao J, et al.: Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Biochem 2009; 107: 134-143.
12. Schoppmann SF, Fenzl A, Nagy K, et al.: VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: Impact on lymphangiogenesis and survival. Surgery 2006; 139: 839-846. (Pubitemid 43902914)
13. Ohno S, Inagawa H, Dhar DK, et al.: Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: The impact on FasL-mediated counterattack. Anticancer Res 2005; 25: 463-470. (Pubitemid 40470051)
14. Gao J, Knutsen A, Arbman G, et al.: Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer. Dig Liver Dis 2009; 41: 116-122.
15. Miyata Y, Kanda S, Ohba K, et al.: Lymphangiogenesis and angiogenesis in bladder cancer: Prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin Cancer Res 2006; 12: 800-806. (Pubitemid 43259860)
16. Shimanuki Y, Takahashi K, Cui R, et al.: Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer. Lung 2005; 183: 29-42. (Pubitemid 41264745)
17. Dobrzycka B, Terlikowski SJ, Kowalczuk O, et al.: Serum levels of VEGF and VEGF-C in patients with endometrial cancer. Eur Cytokine Netw 2011; 22: 45-51.
18. Naumnik W, Izycki T, Swidzinska E, et al.: Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Oncol Res 2007; 16: 445-451.
19. Mitsuhashi A, Suzuka K, Yamazawa K, et al.: Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 2005; 103: 724-730. (Pubitemid 40216400)
20. Maeda S, Omata M,: Inflammation and cancer: Role of nuclear factor-kappaB activation. Cancer Sci 2008; 99: 836-842. (Pubitemid 352002583)
21. Karin M, Greten FR,: NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5: 749-759. (Pubitemid 41400849)
22. Mantovani A, Schioppa T, Porta C, et al.: Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006; 25: 315-322. (Pubitemid 44922352)
23. Siveen KS, Kuttan G,: Role of macrophages in tumour progression. Immunol Lett 2009; 123: 97-102.
24. Sica A, Schioppa T, Mantovani A, et al.: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur J Cancer 2006; 42: 717-727.
25. Lin EY, Pollard JW,: Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res 2007; 67: 5064-5066. (Pubitemid 46997238)
26. Osinsky S, Zavelevich M, Vaupel P,: Tumor hypoxia and malignant progression. Exp Oncol 2009; 31: 80-86.
27. Osinsky S, Bubnovskaya L, Ganusevich I, et al.: Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: Interaction and impact on survival. Clin Transl Oncol 2011; 13: 133-138.
28. Lewis CE, Hughes R,: Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: Hypoxia and angiopoietin-2. Breast Cancer Res 2007; 9: 209.
29. Vicioso L, Gonzalez FJ, Alvarez M, et al.: Elevated serum levels of vascular endothelial growth factor are associated with tumor-associated macrophages in primary breast cancer. Am J Clin Pathol 2006; 125: 111-118. (Pubitemid 43089733)
30. Hagemann T, Biswas SK, Lawrence T, et al.: Regulation of macrophage function in tumors: The multifaceted role of NF-kappaB. Blood 2009; 113: 3139-3146.
31. Skobe M, Hamberg LM, Hawighorst T, et al.: Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001; 159: 893-903. (Pubitemid 32847180)
32. Gonzalez FJ, Vicioso L, Alvarez M, et al.: Association between VEGF expression in tumour-associated macrophages and elevated serum VEGF levels in primary colorectal cancer patients. Cancer Biomark 2007; 3: 325-333. (Pubitemid 350187033)
33. Hagemann T, Wilson J, Kulbe H, et al.: Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 2005; 175: 1197-1205. (Pubitemid 41095008)
34. Kiriakidis S, Andreakos E, Monaco C, et al.: VEGF expression in human macrophages is NF-kappaB-dependent: Studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2. J Cell Sci 2003; 116: 665-674. (Pubitemid 36231305)
35. Watari K, Nakao S, Fotovati A, et al.: Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun 2008; 377: 826-831.
36. Mancino A, Lawrence T,: Nuclear factor-kappaB and tumor-associated macrophages. Clin Cancer Res 2010; 16: 784-789.